Patents by Inventor Jorge Alberto Reyes Esparza

Jorge Alberto Reyes Esparza has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Beta-hydroxy-gamma-aminophosphonates for treating immune disorders
    Patent number: 9492466
    Abstract: The present disclosure provides methods of treating, ameliorating, or preventing immune disorders, allergic disorders, or inflammatory disorders, or combinations thereof, or providing hepatoprotection in subject. In one aspect, the method comprises administering to a subject a therapeutically effective amount of a ?-hydroxy-?-aminophosphonate or ?-amino-?-aminophosphonate.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: November 15, 2016
    Assignee: Nucitec S.A. de C.V.
    Inventors: Ricardo Abraham De La Cruz Cordero, Jorge Luis Rosado Loria, Miguel Angel Duarte Vazquez, José Mario Ordóñez Palacios, Jorge Alberto Reyes Esparza, Maria de Lourdes Rodriguez Fragoso
  • IMMUNOMODULATOR METALLOPEPTIDES (IMMPS) AND COMPOSITIONS CONTAINING SAME
    Publication number: 20150132328
    Abstract: The present invention relates to the field of human and veterinary medicine. The invention solves the problem associated with the lack of an agent for improving the immune response in immunosuppressed individuals, or with autoimmunity problems as well as infections; reducing the effects of the stress, combating tissue fibrosis; the need for anti-inflammatory agents; treatments for acute and chronic hepatitis, treatments against malignant processes and metastasis, as well as thrombocytopenia, both in humans and animals. The present invention comprises a molecular complex formed by a metallic ion and a peptide as novel compound, which is denominated as an immunomodulator metallopeptide hereafter abbreviated as IMMP. Claims also include the process for obtaining the complex, the use of the metallopeptide for producing a therapeutic or nutraceutic agent, and the use of that agent in humans and animals.
    Type: Application
    Filed: October 4, 2011
    Publication date: May 14, 2015
    Applicant: UNIVERSIDAD AUTONOMA DEL ESTADO DE MORELOS
    Inventors: Jorge Alberto Reyes Esparza, Maria de Lourdes Rodriguez Fragoso, Ana Laura Badillo Jimenez, Lorena Julieta Torres Aguilar, Lorenzo Ulises Martinez Osuna, Abril Arianna Martinez De Los Rios Corsino, Carlos Antonio Arjona Canul, Hugo Morales Rojas
  • Amphotericin Analogous Compounds and Pharmaceutical Compositions Containing Them
    Publication number: 20140256663
    Abstract: The present invention relates to polyene macrolide derivatives according to the formula: wherein M is a macrocyclic lactone ring; N is a polyene sugar, substituted or unsubstituted; X is independently selected from O, S, N or NH; R is independently selected from an alkyl, cycloalkyl, heterocycloalkyl aryl, heteroaryl, arylalkyl, and heteroaryalkyl group; and i is an integer from 1 to 3, with the condition that it has a negative charge or the zwitterions character is restored; or a pharmaceutically acceptable salt thereof useful as antibiotics.
    Type: Application
    Filed: December 16, 2011
    Publication date: September 11, 2014
    Applicants: CENTRO DE INVESTIGACION Y DE ESTUDIOS AVANZADOS DEL INSTITUTO POLITECNICO AACION, UNIVERSIDAD NACIONAL AUTONOMA DE MEXICO, UNIVERSIDAD AUTONOMA DEL ESTADO DEMORLOS
    Inventors: Armando Antillon Diaz, Maurico Carrillo Tripp, Mario Fernandez Zertuche, Jose David Flores Romero, Fabiola Eloisa Jimenez Montejo, Angel Leon Buitimea, Rosmarbel Morales Nava, Lilia Ocampo Martinez, Ivan Ortega Blake, Jorge Alberto Reyes Esparza, Maria de Lourdes Rodriguez Frangoso, Tania Minerva Santiago Angelino, Maria Cristina Vargas Gonzalez
  • Beta-hydroxy-gamma-aminophosphonates for Treating Immune Disorders
    Publication number: 20140107079
    Abstract: The present disclosure provides methods of treating, ameliorating, or preventing immune disorders, allergic disorders, or inflammatory disorders, or combinations thereof, or providing hepatoprotection in subject. In one aspect, the method comprises administering to a subject a therapeutically effective amount of a ?-hydroxy-?-aminophosphonate or ?-amino-?-aminophosphonate.
    Type: Application
    Filed: March 14, 2013
    Publication date: April 17, 2014
    Applicant: Nucites S.A. de C.V.
    Inventors: Ricardo Abraham De La Cruz Cordero, Jorge Luis Rosado Loria, Miguel Angel Duarte Vazquez, José Mario Ordóñez Palacios, Jorge Alberto Reyes Esparza, Maria de Lourdes Rodriguez Fragoso